Physician profile
Gregory Vo
NPI 1154856318
$1,460.41
in general payments reported to CMS, 2019-2025
16 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $285 · 2022: $716 · 2023: $195 · 2024: $100 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.22 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $333.06 | 2021-2023 | Opsumit |
| Abiomed | $312.56 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $138.34 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $128.02 | 2021-2023 | Recarbrio, Zerbaxa, Dificid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.17 | 2021-2023 | Ofev |
| Ceribell, INC. | $100.00 | 2024 | Pocket Eeg Device |
| Baxter Healthcare | $98.46 | 2022 | |
| Insmed, INC. | $82.12 | 2021-2023 | Arikayce |
| E.R. Squibb & Sons, L.L.C. | $27.78 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.51 | 2023 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $19.72 | 2022 | |
| Glaxosmithkline, LLC. | $16.26 | 2021 | |
| Grifols USA, LLC | $16.15 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.76 | 2023 | Fasenra |
| Gilead Sciences, INC. | $14.86 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.